GE HealthCare Technologies Inc. Common Stock vs Goodyear Tire & Rubber Co — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while Goodyear Tire & Rubber Co trades at $4.39 (market cap $1.31B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 23.7× Goodyear Tire & Rubber Co's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Goodyear Tire & Rubber Co pays none. Which is the better fit depends on your goals.
| GEHC | GT | |
|---|---|---|
Market Cap | $31.07B | $1.31B |
Volume | 3,443,020 | 8,331,802 |
Sector | Health | Consumer Cyclical |
52-Week High | $88.16 | $10.54 |
52-Week Low | $59.48 | $4.38 |
Enterprise Value | $39.53B | $8.66B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 58 Days |
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
The Goodyear Tire & Rubber Company (GT) trades at $4.38, down 2.45% on the day, reflecting persistent bearish technical momentum. The stock shows deeply discounted valuation ratios, including a P/E of 4.69 and P/B of 0.46, but faces significant fundamental challenges with a net income margin of -14.37% and negative ROE of -63.93% for 2025. Recent earnings have been mixed, with Q2 2026 beating expectations but still posting a loss. Cash flow trends show modest improvement, with net cash flow turning positive in 2025 and 2026. Analyst sentiment is mixed, with a consensus price target of $8.00 implying substantial upside, though technical indicators remain bearish overall.
Outlook: GT presents a high-risk, high-reward opportunity. The stock is fundamentally undervalued, and successful execution of its restructuring and margin expansion strategy could drive significant appreciation toward the analyst target. However, persistent losses, high debt, and competitive pressures pose substantial risks. Investors should weigh the potential for a turnaround against the company's current financial instability and bearish market sentiment.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.
Read more on GT →